ES8701193A1 - Un procedimiento para preparar derivados de acido griseolico - Google Patents

Un procedimiento para preparar derivados de acido griseolico

Info

Publication number
ES8701193A1
ES8701193A1 ES547291A ES547291A ES8701193A1 ES 8701193 A1 ES8701193 A1 ES 8701193A1 ES 547291 A ES547291 A ES 547291A ES 547291 A ES547291 A ES 547291A ES 8701193 A1 ES8701193 A1 ES 8701193A1
Authority
ES
Spain
Prior art keywords
acid derivatives
griseolic acid
image
griseolic
pde
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES547291A
Other languages
English (en)
Other versions
ES547291A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sankyo Co Ltd
Original Assignee
Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co Ltd filed Critical Sankyo Co Ltd
Publication of ES8701193A1 publication Critical patent/ES8701193A1/es
Publication of ES547291A0 publication Critical patent/ES547291A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Hospice & Palliative Care (AREA)
  • Hematology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Insulating Materials (AREA)
  • Fats And Perfumes (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE DERIVADOS DE ACIDO GRISEOLICO, DE FORMULA (I). CONSISTE EN LA REACCION DE UN COMPUESTO DE FORMULA (II), CON UN HALOGENO EN UNA DISOLUCION ACUOSA ALCALINA DE PH MAYOR QUE 12, EN PRESENCIA DE UN DISOLVENTE INERTE, A UNA TEMPERATURA COMPRENDIDA ENTRE 0JC Y LA AMBIENTE; SEGUIDA DE TRATAMIENTO OPCIONAL DEL PRODUCTO FORMADO CON UN AGENTE ESTERIFICANTE ADECUADO A UNA TEMPERATURA ENTRE C20JC Y 100JC, PARA OBTENER EL COMPUESTO DE FORMULA (I), EN LA QUE Z ES UN HALOGENO Y R13K ES HIDROGENO O UN GRUPO PROTECTOR DEL CARBOXILO. ESTOS COMPUESTOS TIENEN APLICACIONES FARMACOLOGICAS COMO AGENTE ANGIOCARDIOCINETICO, ANTIASMATICO, ANTICANCEROSO Y ANTIINFLAMATORIO.
ES547291A 1983-10-28 1985-09-25 Un procedimiento para preparar derivados de acido griseolico Expired ES8701193A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58202362A JPS6094992A (ja) 1983-10-28 1983-10-28 グリゼオ−ル酸誘導体

Publications (2)

Publication Number Publication Date
ES8701193A1 true ES8701193A1 (es) 1986-11-16
ES547291A0 ES547291A0 (es) 1986-11-16

Family

ID=16456245

Family Applications (4)

Application Number Title Priority Date Filing Date
ES537154A Granted ES537154A0 (es) 1983-10-28 1984-10-26 Un procedimiento para preparar derivados de acido griseolico
ES547292A Expired ES8604981A1 (es) 1983-10-28 1985-09-25 Un procedimiento para preparar derivados de acido griseolico
ES547291A Expired ES8701193A1 (es) 1983-10-28 1985-09-25 Un procedimiento para preparar derivados de acido griseolico
ES547347A Expired ES8700673A1 (es) 1983-10-28 1985-09-26 Un procedimiento para preparar derivados de acido griseolico

Family Applications Before (2)

Application Number Title Priority Date Filing Date
ES537154A Granted ES537154A0 (es) 1983-10-28 1984-10-26 Un procedimiento para preparar derivados de acido griseolico
ES547292A Expired ES8604981A1 (es) 1983-10-28 1985-09-25 Un procedimiento para preparar derivados de acido griseolico

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES547347A Expired ES8700673A1 (es) 1983-10-28 1985-09-26 Un procedimiento para preparar derivados de acido griseolico

Country Status (12)

Country Link
US (1) US4634706A (es)
EP (1) EP0143557B1 (es)
JP (1) JPS6094992A (es)
KR (1) KR930000165B1 (es)
AT (1) ATE39357T1 (es)
CA (1) CA1267408A (es)
DE (1) DE3475714D1 (es)
DK (1) DK166323C (es)
ES (4) ES537154A0 (es)
FI (1) FI81357C (es)
NO (1) NO164904C (es)
SU (4) SU1600632A3 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4783532A (en) * 1983-10-28 1988-11-08 Sankyo Company Limited Process for preparing griseolic acid derivatives
IT1196261B (it) * 1984-09-20 1988-11-16 Pierrel Spa Derivati nucleosidici e purinici 8-sostituiti
EP0319050B1 (en) 1985-04-19 1995-04-12 Sankyo Company Limited Griseolic acid derivatives, their preparation and their use
FI94133C (fi) * 1985-04-19 1995-07-25 Sankyo Co Menetelmä lääkeaineina käyttökelpoisten griseoliinihapon johdannaisten valmistamiseksi
JPH0631307B2 (ja) * 1985-04-27 1994-04-27 三共株式会社 グリゼオ−ル酸誘導体の製法
US5214048A (en) * 1987-05-19 1993-05-25 Nippon Kayaku Kabushiki Kaisha Oxetanocins
JPH0774229B2 (ja) * 1987-12-02 1995-08-09 三共株式会社 グリゼオール酸モノエステル誘導体
US5091431A (en) * 1988-02-08 1992-02-25 Schering Corporation Phosphodiesterase inhibitors
JPH0689020B2 (ja) * 1988-06-30 1994-11-09 三共株式会社 グリゼオール酸のモノエステル誘導体
US4971972A (en) * 1989-03-23 1990-11-20 Schering Corporation Phosphodiesterase inhibitors having an optionally substituted purine derivative portion and a benzo- or cyclopenta-furan portion
JP3645580B2 (ja) * 1993-10-22 2005-05-11 株式会社フジモト・ブラザーズ グルコースエステル誘導体を含有する脳代謝改善剤
US6291516B1 (en) 1999-01-13 2001-09-18 Curis, Inc. Regulators of the hedgehog pathway, compositions and uses related thereto
EP1312363A1 (en) * 2001-09-28 2003-05-21 Pfizer Products Inc. Methods of treatment and kits comprising a growth hormone secretagogue
US7342884B2 (en) * 2002-03-13 2008-03-11 Harmonic, Inc. Method and apparatus for one directional communications in bidirectional communications channel
WO2011081915A2 (en) * 2009-12-15 2011-07-07 Cebix Inc. Methods for treating erectile dysfunction in patients with insulin-dependent diabetes
CN113039001B (zh) * 2021-02-19 2022-10-18 安徽金禾实业股份有限公司 蔗糖-6-酯的生产设备及生产方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3862189A (en) * 1973-08-14 1975-01-21 Warner Lambert Co Aralkyl-substituted purines and pyrimidines as antianginal bronchodilator agents
GB1523865A (en) * 1974-09-02 1978-09-06 Wellcome Found Purine compunds and salts thereof
US4138562A (en) * 1977-02-09 1979-02-06 The Regents Of The University Of Minnesota Adenosine deaminase resistant antiviral purine nucleosides and method of preparation
JPS5668695A (en) * 1979-11-10 1981-06-09 Sankyo Co Ltd Enzyme inhibitor griseolic acid and its preparation
DE3028273A1 (de) * 1980-07-25 1982-02-25 Fa. Dr. Willmar Schwabe, 7500 Karlsruhe Durch purinbasen substituierte 1.4;3.6-dianhydro-hexit-nitrate
JPS60246396A (ja) * 1984-05-22 1985-12-06 Sankyo Co Ltd 酵素阻害物質ジヒドロデスオキシグリゼオ−ル酸及びその塩類

Also Published As

Publication number Publication date
SU1468422A3 (ru) 1989-03-23
SU1600632A3 (ru) 1990-10-15
NO844291L (no) 1985-04-29
ES8604981A1 (es) 1986-02-16
ATE39357T1 (de) 1989-01-15
NO164904B (no) 1990-08-20
DK166323B (da) 1993-04-05
SU1468421A3 (ru) 1989-03-23
KR930000165B1 (ko) 1993-01-11
EP0143557A3 (en) 1985-07-03
FI844225A0 (fi) 1984-10-26
NO164904C (no) 1990-11-28
JPS6094992A (ja) 1985-05-28
ES8604737A1 (es) 1985-12-01
ES547291A0 (es) 1986-11-16
ES8700673A1 (es) 1986-10-16
FI81357C (fi) 1990-10-10
CA1267408A (en) 1990-04-03
SU1604158A3 (ru) 1990-10-30
KR850003415A (ko) 1985-06-17
DK513384D0 (da) 1984-10-26
EP0143557B1 (en) 1988-12-21
US4634706A (en) 1987-01-06
FI81357B (fi) 1990-06-29
DE3475714D1 (en) 1989-01-26
ES547347A0 (es) 1986-10-16
DK166323C (da) 1993-08-30
ES547292A0 (es) 1986-02-16
DK513384A (da) 1985-04-29
FI844225L (fi) 1985-04-29
ES537154A0 (es) 1985-12-01
JPH0432837B2 (es) 1992-06-01
EP0143557A2 (en) 1985-06-05

Similar Documents

Publication Publication Date Title
ES8700673A1 (es) Un procedimiento para preparar derivados de acido griseolico
NZ515669A (en) Beta 2 adrenoceptor agonists
HU900228D0 (en) Process for preparation of pyrazolo-pyridines
ZA943100B (en) Benzofuranyl- and -thiophenyl-alkanecarboxyclic acid derivatives
GR3023938T3 (en) 3',5'-ditertbutyl-4'-hydroxyflavones, method for their preparation and pharmaceutical compositions with an antioxidant and antivasoconstricting activity
ZA911728B (en) Benzisothiazolinone-1-dioxide derivatives as elastase inhibitors
GR3024686T3 (en) Novel guinolone and naphthyridone derivatives.
ES8305325A1 (es) "procedimiento para preparar derivados de 2-oxoazetidina".
EP0321968A3 (en) Compounds active on the cardiovascular system
ES8407321A1 (es) "un procedimiento para preparar un compuesto organico de selenio"
DE3570249D1 (en) Enzyme-inhibitory griseolic acid derivatives, and their use
MY110092A (en) Butyric acid derivatives
ATE50248T1 (de) Ein imidazolidintrion-derivat oder ein seiner pharmazeutisch akzeptierbaren salze enthaltende pharmazeutische zusammenstellung.
AU7935887A (en) Therapeutic agent for the treatment of peptic ulcer disease
ES8308317A1 (es) Procedimiento de preparacion de nuevos derivados de 2-fenilmorfolina.
EP0618204A4 (en) HETEROCYCLIC COMPOUND AND THIS CARDIOTONIC CONTAINING IT AS AN ACTIVE COMPONENT.
ES8207542A1 (es) Un procedimiento para la preparacion de 1rs,4rs,5rs-4-(4,8 dimetil-5-hidroxi-7-nomen-1-1-il)-4-metil-3,8-dioxabiciclo(3.2.1)octano-1.aletico.
ES8303297A1 (es) Un procedimiento para la preparacion de un nuevo reptido activo.
GB1470747A (en) Pyridazine derivative
GEP19980890B (en) Derivatives of N1-(1,2-Cis-halogeno¬-cyclopropyl) Substituted Pyridonecarbonic Acid
EP0321967A3 (en) Compounds active on the cardiovascular system
WO1987003479A3 (en) Medicament for use against circulatory disorders
EP0318060A3 (en) Griseolic acid derivatives, their preparation and their use
JPS6419019A (en) Antiamnestic agent
TW343973B (en) Morphinan derivative and medical use